Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
The stock is well placed above its 20, 50 and 100 day-SMA which supports bullish sentiments ahead. It can be bought in the range of Rs 600-650, says Rajesh Palviya of Axis Securities.
We believe that the negative sentiment in the forex and the bond market could continue for a while in the absence of any concrete measures by the policymakers
Rahul Mohindar of viratechindia.com is of the view that one can sell Tata Consultancy Services with target of Rs 2085 and stop loss at Rs 2085 and buy Dr Reddy's Laboratories with target of Rs 2680 and stop loss at Rs 2460.
We believe Sun Pharmaceutical Industries is the best play in pharma space and investors can add this stock to their long-term portfolio, says Akash Jain of Ajcon Global.
Brokerage house sees upside potential of 16 percent on the back of potential earnings upgrades.
says Aditya Agarwal of Way2Wealth Brokers.
The Sensex and Nifty rallied more than 9 percent each to scale new highs of 38,989.65 and 11,760.20 respectively in current week while the BSE Midcap index jumped over 8 percent and Smallcap climbed over 6 percent in two months.
Prakash Gaba of prakashgaba.com suggests buying India Cements with target at Rs 133 and stop loss at Rs 124, ITC with target at Rs 325 and stop loss at Rs 315 and Sun Pharma Advanced with target at Rs 425 and stop loss at Rs 390.
On daily charts, Nifty is forming a bearish divergence, therefore, the possibility of further profit booking can’t be ruled out even from current levels.
Rajesh Agarwal of AUM Capital recommends buying J Kumar Infraprojects with stop loss at Rs 264 and target of Rs 280, Power Grid Corp with stop loss at Rs 192 and target of Rs 200 and ITC with stop loss at Rs 313 and target of Rs 329.
It said that the risk mitigation of Absorica (acne medication) should drive rerating on the stock, but a genericisation in December 2020 is a key overhang.
Traders should prepare themselves for an eventful week and keep a close eye on global developments along with the domestic factors.
If Nifty holds above 11,480, we expect the rally to continue towards 11,700-11,750 levels. On the downside, immediate support is seen at 11,480. A break below this level would see profit booking towards 11,340, says Ashish Chaturmohta of Sanctum Wealth Management.
The stock has given strong technical break out on weekly chart after long consolidation. We are recommending a buy for short to long term, says Sumit Bilgaiyan of Equity99.
Global clues will continue to dominate market sentiments in the absence of any major domestic events. The rupee will be in focus as it closed above the Rs 70/$ for the first time
Nifty looks strong on the charts but requires sustainability above 11,525 for further upward movement else we might see extended consolidation.
The short term trend is likely to reverse only if the Nifty breaches the 11,340 on a closing basis, says Hadrien Mendonca of IIFL
Rajesh Agarwal of AUM Capital recommends buying International Paper with stop loss at Rs 472 and target of Rs 500, RITES with stop loss at Rs 278 and target of Rs 295 and Punjab National Bank with stop loss at Rs 79 and target of Rs 85.
CLSA and HSBC remained positive on the stock but Citi maintained its Neutral call and Prabhudas Lilladher Reduce rating on Sun Pharma.
Rajesh Agarwal of AUM Capital is of the view that one can buy Sun Pharmaceutical Industries with stop loss at Rs 584 and target of Rs 625 and Aditya Birla Fashion with stop loss at Rs 187 and target of Rs 200 and can sell Kotak Mahindra Bank with stop loss at Rs 1310 and target of Rs 1260.
The rupee's fall is technical in nature and should be viewed in accordance with happenings across the globe.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Ashok Leyland with a stop loss of Rs 118, target of Rs 126 and can sell HDFC with a stop loss of Rs 1945, target of Rs 1890 and Larsen & Toubro with a stop loss of Rs 1300, target of Rs 1240.
The key thing to watch out in the current rally is Nifty midcap and small-cap rallies are getting elongated along with contracting declines (as the current rally is bigger than early July pullback) underpinned by improved market breadth and volumes, says Dharmesh Shah of ICICI Direct.com Research.
World Crest Advisors LLP bought 44,62,38,855 shares of Dish TV India through market purchase on July 24, 2018 while Hindustan Times bought 1,41,000 shares of Chambal Fertilisers & Chemicals through market purchase on July 27, 2018 and Eriez Industries Pvt.Ltd. bought 40,086 shares of 20 Microns Ltd through market purchase on July 27, 2018.
Mitessh Thakkar of mitesshthakkar.com recommends buying KPIT Technologies with a stop loss of Rs 301 and target of Rs 320 and Sun Pharmaceutical Industries with a stop loss of Rs 564 and target of Rs 595 and advises selling Colgate Palmolive with a stop loss of Rs 1136 and target of Rs 1090.